Neurofibrillary tangles in the peripheral sympathetic ganglia of patients with myotonic dystrophy

Neuropathology and Applied Neurobiology

Volumn 39, Issue 5, 2013, Pages 585-588

  Kuru, S ^a   Sakai, M ^a   Yoshida, M ^b   Mimuro, M ^b   Hashizume, Y ^c  

^a National Hospital Organization   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Fukushimura Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOLISM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BEHCET DISEASE; CENTRAL PONTINE MYELINOLYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; FEMALE; GANGLION; HUMAN; LETTER; LEWY BODY; MALE; MYOTONIC DYSTROPHY; NEUROFIBRILLARY TANGLE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; TAUOPATHY;

AGED; FEMALE; GANGLIA, SYMPATHETIC; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; NEUROFIBRILLARY TANGLES;

EID: 84880170272     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12043     Document Type: Letter

References (12)

1. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophy: a review. Muscle Nerve 2005; 32: 1-18
2. Kiuchi A, Otsuka N, Namba I, Nakano I, Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol (Berl) 1991; 82: 1-5
3. Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I, Kashima H. Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 2006; 26: 107-114
4. Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol (Berl) 2010; 120: 1-12
5. Kawasaki H, Murayama S, Tomonaga M, Izumiyama N, Shimada H. Neurofibrillary tangles in human upper cervical ganglia. Morphological study with immunohistochemistry and electron microscopy. Acta Neuropathol (Berl) 1987; 75: 156-159
6. Sergeant N, Sablonnière B, Schraen-Maschke S, Ghestem A, Maurage CA, Wattez A, Vermersch P, Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 2001; 10: 2143-2155
7. Wakabayashi K, Hayashi S, Morita T, Shibasaki Y, Watanabe Y, Takahashi H. Neurofibrillary tangles in the peripheral sympathetic ganglia of non-Alzheimer elderly individuals. Clin Neuropathol 1999; 18: 171-175
8. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004; 13: 3079-3088
9. Delacourte A, Buée L. Tau pathology: a marker of neurodegenerative disorders. Curr Opin Neurol 2000; 3: 371-376
10. 123I-Metaiodobenzylguanidine myocardial scintigraphy for evaluating the severity of myotonic dystrophy. J Auton Nerv Syst 1996; 33: 559-565
11. Inoue K, Ogata H, Matsui M, Hayano J, Miyake S, Kumasiro M, Kuno M, Tokonami F, Aii H, Akatsu J. Assesssment of autonomic function in myotonic dystrophy by spectral analysis of heart-rate variability. J Auton Nerv Syst 1995; 55: 131-134
12. Rakocevic-Stojanovic V, Milovanovic B, Ivic N, Ille T, Marjanovic I, Stevic Z, Pavlovic S, Lavrnic D. Cardiac autonomic system in patients with myotonic dystrophy type 1. Acta Myol 2007; 26: 112-114